Methodological quality of clinical guidelines for universal newborn hearing screening

• Published in: Developmental medicine and child neurology Vol. 63; no. 1; pp. 16 - 21
• Main Authors: Kamenov, Kaloyan, Chadha, Shelly
• Format: Journal Article
• Language: English
• Published: England 01.01.2021
• Subjects: Hearing Loss - diagnosis; Hearing Tests - standards; Humans; Infant, Newborn; Neonatal Screening - standards; Practice Guidelines as Topic - standards
• ISSN: 0012-1622; 1469-8749; 1469-8749
• DOI: 10.1111/dmcn.14694

Aim To review existing guidelines for universal newborn hearing screening (UNHS), identify those that provide comprehensive and clear recommendations on the subject, and provide a brief overview. Method A scoping literature review was performed in PubMed, the Guidelines International Network library, and national guideline databases to identify guidelines on newborn hearing screening developed or updated between 2004 and 2019. The quality of the guidelines was checked with the Checklist for the Quality Assessment of Guidelines (AGREE II). Results Six guidelines met all the inclusion criteria. All six were based on the 1‐3‐6 benchmark (screening completed by 1mo, audiological diagnosis by 3mo, enrolment in early intervention by 6mo). However, the guidelines varied in terms of their recommendations for the application of screening methods, role of health professionals in the screening process, and quality. Based on the AGREE II score, flexibility, adaptability, and foundation role for all other guidelines, the 2019 guidelines of the Joint Committee on Infant Hearing position statement were identified as the most appropriate to be recommended for adaptation by countries or programmes. Interpretation The diversity in the existing guidance can be confusing for countries and institutions that are planning to develop universal hearing screening programmes. As more countries and organizations develop their newborn hearing screening programmes, they will need examples to emulate. This review provides an evaluation of the quality, comprehensiveness, and applicability of existing clinical guidelines that can serve as a facilitator for countries, institutions, or organizations in their planning and implementation of a UNHS programme. This article is commented on by Gubbels on pages 7 of this issue.